ライフサイエンスコーパス: central apnea

1 an abnormal rhythm discharge with periods of central apnea.

2 espiration in an established animal model of central apnea.

3 w the apneic threshold, thereby resulting in central apnea.

4 associated with suppression of sleep-related central apnea.

5 and alternate apnea type for obstructive and central apnea.

6 nt cause of irregular breathing patterns and central apneas.

7 Also, WHBPs from Mecp2(-/y) showed central apneas.

8 Most of these events were central apneas.

9 tazolamide, the hourly number of episodes of central apnea (49 +/- 28 vs. 23 +/- 21 [mean +/- SD]; p

10 Among patients with central apneas, adding dead space decreased sleep fragme

11 reproduces the respiratory phenotype of PWS (central apnea and blunted response to respiratory challe

12 In older men, central apnea and Cheyne-Stokes respiration predicted in

13 All 8 animals demonstrated central apnea and hypoventilation, which resulted in the

14 eviously unrecognized neurological features, central apnea and neurogenic upper airway collapse, toge

15 We found that central apnea and O2 desaturation occurred when seizures

16 ackup rate and wakefulness drive can lead to central apneas and sleep fragmentation, especially in pa

17 fection in children, which include seizures, central apnea, and encephalopathy.

18 However, central apnea appeared to account for this monotonic rel

19 Theophylline has been used to treat central apnea associated with Cheyne-Stokes respiration

20 Central apnea attack might be occurred in patient with I

21 isposed pups not only to hypoventilation and central apneas, but also to obstructive and mixed apneas

22 noninvasive mechanical ventilation to treat central apnea (CA) occurring at night ("sleep apnea") in

23 The feasibility of detecting obstructive and central apneas, cardiopulmonary coupling, and the hemody

24 Central apnea, Cheyne-Stokes respiration, and sleep-diso

25 PaCO2 results in ventilatory instability and central apnea during sleep.

26 a 50-fold dose range, significantly reduces central apnea expression during NREM and REM sleep in th

27 Ictal central apnea (ICA) is a semiological sign of focal epil

28 Because pressure support predisposes to central apneas in healthy subjects, we examined whether

29 ight CSR had the greatest apnea-hypopnea and central apnea index (at daytime and nighttime), the wors

30 the obstructive apnea-hypopnea index (AHI), central apnea index (CAI >/= 5), and Cheyne-Stokes breat

31 6, 8.7, and 5.3, respectively; all p < 0.05; central apnea index [CAI] of </>/=10 events/h; log-rank

32 : apnea-hypopnea index, central sleep apnea (central apnea index, >/=5 vs. <5), central sleep apnea o

33 eater increases in both mean obstructive and central apnea indices, by 1.75 events per hour (95% conf

34 al cerebral dysfunction, possibly leading to central apnea, may be a pathogenetic mechanism for SUDEP

35 Central apneas occur after cessation of mechanical venti

36 Central apneas occurred during pressure support in six p

37 2.72-36.50), Cheyne-Stokes respiration with central apnea (OR, 6.31; 95% CI, 1.94-20.51), and apnea-

38 counts), atrial fibrillation was related to central apnea (OR, 9.97; 95% CI, 2.72-36.50), Cheyne-Sto

39 se line; P<0.001), the number of episodes of central apnea per hour (6 +/- 14, vs. 26 +/- 21 and 26 +

40 eep apnea had significantly more episodes of central apnea per hour than those without central sleep

41 The density and average duration of central apneas remained unchanged.

42 diazepines in an established animal model of central apnea, we administered nonhypnotic and hypnotic

43 The former also had significantly more central apnea, which occurred more commonly during non-r

44 , and diaphragmatic activities, resulting in central apnea with laryngeal closure; and (2) these lary